Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

ABSTRACT:

Importance

The incidence and prevalence of neuroendocrine tumors (NETs) are thought to be rising, but updated epidemiologic data are lacking.

Objective

To explore the evolving epidemiology and investigate the effect of therapeutic advances on survival of patients with NETs.

Design, setting, and participants

A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER) program was conducted to evaluate 64 971 patients with NETs from 1973 to 2012. Associated population data were used to determine annual age-adjusted incidence, limited-duration prevalence, and 5-year overall survival (OS) rates. Trends in survival from 2000 to 2012 were evaluated for the entire cohort as well as specific subgroups

SUBMITTER: Dasari A 

PROVIDER: S-EPMC5824320 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature